Inc. , today announced a definitive merger agreement under which Bristol Myers Squibb ("BMS") will acquire all of the outstanding shares of 2seventy bio at a price of $5.00 per share in an all-cash ...

ACTG, a global clinical trials network focused on HIV and other infectious diseases, today presented findings from the REPRIEVE trial about the use of statins among people living with HIV with frailty ...

Incident HCV infection more than doubled among HIV-positive MSM with no history of injection drug use between 1995 and 2023.

StockNews.com upgraded shares of Kamada (NASDAQ:KMDA – Free Report) from a buy rating to a strong-buy rating in a report released on Thursday. Separately, HC Wainwright restated a “buy” rating and ...

Daily science news on research developments and the latest scientific innovations Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech ...

For Bleeding Disorders Awareness Month, columnist Jennifer Lynne checks in with some who've responded to struggles with advocacy.

After hours: March 12 at 6:44:02 PM EDT Loading Chart for KMDA ...

After hours: March 14 at 4:10:12 PM EDT Loading Chart for ALVR ...